首页> 外文OA文献 >MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells
【2h】

MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells

机译:miR-129-5p是甲状腺癌细胞中组蛋白去乙酰化酶抑制剂诱导的细胞死亡所必需的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The molecular mechanism responsible for the antitumor activity of histone deacetylase inhibitors (HDACi) remains elusive. As HDACi have been described to alter miRNA expression, the aim of this study was to characterize HDACi-induced miRNAs and to determine their functional importance in the induction of cell death alone or in combination with other cancer drugs. Two HDACi, trichostatin A and vorinostat, induced miR-129-5p overexpression, histone acetylation and cell death in BCPAP, TPC-1, 8505C, and CAL62 cell lines and in primary cultures of papillary thyroid cancer (PTC) cells. In addition, miR-129-5p alone was sufficient to induce cell death and knockdown experiments showed that expression of this miRNA was required for HDACi-induced cell death. Moreover, miR-129-5p accentuated the anti-proliferative effects of other cancer drugs such as etoposide or human a-lactalbumin made lethal for tumor cells (HAMLET). Taken together, our data show that miR-129-5p is involved in the antitumor activity of HDACi and highlight a miRNA-driven cell death mechanism. Endocrine-Related Cancer (2011) 18 711-719
机译:负责组蛋白脱乙酰基酶抑制剂(HDACi)的抗肿瘤活性的分子机制仍然不清楚。由于已经描述了HDACi会改变miRNA的表达,因此本研究的目的是表征HDACi诱导的miRNA,并确定其在单独或与其他癌症药物联合诱导细胞死亡中的功能重要性。两种HDACi,曲古抑菌素A和伏立诺他在BCPAP,TPC-1、8505C和CAL62细胞系以及乳头状甲状腺癌(PTC)细胞的原代培养物中诱导miR-129-5p过表达,组蛋白乙酰化和细胞死亡。此外,单独的miR-129-5p足以诱导细胞死亡,并且敲低实验表明,这种miRNA的表达对于HDACi诱导的细胞死亡是必需的。此外,miR-129-5p增强了其他抗癌药的抗增殖作用,例如依托泊苷或对肿瘤细胞具有致命性的人α-乳白蛋白(HAMLET)。综上所述,我们的数据表明miR-129-5p参与了HDACi的抗肿瘤活性,并突出了miRNA驱动的细胞死亡机制。内分泌相关癌症(2011)18 711-719

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号